Trusted Resource for Clinical Trials, Protocols & Progress
Sample Size Challenges in NI vs Superiority Trials – Clinical Trial Design and Protocol Development “Difficulties with Sample Size in Non-Inferiority vs Superiority Trials” Introduction When planning a clinical trial, one of the most crucial decisions entails determining the appropriate sample size. This decision can significantly impact the statistical power of the trial and ultimately…
Regulatory Considerations for Blinded Trials – Clinical Trial Design and Protocol Development “Compliance Factors for Blind Trials” Introduction Blinded trials are an essential component of clinical research and are designed to reduce bias by preventing knowledge of treatment allocation from influencing the behavior of researchers, participants, and assessors. However, the execution of these trials requires…
Data Management in Blinded vs Open Trials – Clinical Trial Design and Protocol Development “Comparing Data Management in Blinded and Open Trials” Introduction to Data Management in Clinical Trials In the world of clinical trials, data management is a critical aspect that ensures the integrity and validity of the results. It involves the collection, integration,…
Understanding the Levels of Blinding in Clinical Trials – Clinical Trial Design and Protocol Development “Comprehending the Different Stages of Blinding in Clinical Research” Introduction to Blinding in Clinical Trials In the realm of Clinical Studies, the concept of ‘blinding’ plays a critical role in maintaining the impartiality and accuracy of the trials. Blinding in…
Monitoring Adverse Events in Non-Blinded Trials – Clinical Trial Design and Protocol Development “Tracking Negative Occurrences in Open-Label Trials” Introduction Monitoring adverse events in non-blinded trials is crucial to ensuring the safety of participants and the integrity of the study. Unlike blinded trials, where the investigators are unaware of the treatment given to participants, non-blinded…
Handling Patient-Reported Outcomes in Open-Label Trials – Clinical Trial Design and Protocol Development “Managing Patient-Reported Results in Open-Label Studies” Introduction In open-label clinical trials, both investigators and participants are aware of the treatment given. This transparency introduces a unique set of challenges, particularly when dealing with Patient-Reported Outcomes (PROs). PROs are valuable data points in…
Innovative Uses of Single-Arm Trials in Early Phases – Clinical Trial Design and Protocol Development “Creative Applications of Single-Arm Trials in Initial Stages” Introduction Single-arm trials are increasingly gaining popularity in early phase clinical studies due to their innovative applications. This experimental design, where all participants receive the investigational treatment, offers some advantages over randomized…
Bias and Interpretation Issues in Single-Arm Trials – Clinical Trial Design and Protocol Development “Challenges of Bias and Interpretation in Single-Arm Trials” Introduction Single-arm trials have become increasingly popular in clinical research, primarily when evaluating the efficacy of new treatments in rare diseases or severe conditions where a placebo control could be deemed unethical. In…
Use of Single-Arm Trials in Rare Diseases – Clinical Trial Design and Protocol Development “Implementing Single-Arm Trials for Rare Disease Treatment” Introduction The complexities of conducting clinical trials in rare diseases are numerous, including small patient populations, heterogeneity of disease presentation, and a lack of existing treatment options. One approach that has gained traction in…
Handling Missing Data in Cluster Trials – Clinical Trial Design and Protocol Development “Managing Absent Information in Cluster Trials” Introduction Missing data is a common challenge when conducting cluster trials in clinical studies. It can compromise the integrity of your data and lead to biased results. This article will guide you on how to handle…
